期刊文献+

原发性高血压患者血浆脂联素和LOX-1的水平变化及相关性 被引量:6

Plasma levels of adiponectin and LOX-1 and their correlation in patients with essential hypertension
下载PDF
导出
摘要 目的:探讨脂联素、LOX-1与原发性高血压发生、发展的关系。方法:收集120例原发性高血压患者,根据血压水平分组,高血压1级(37例),2级(40例),3级43例,同时选取健康对照40例。于肘静脉采血,采用ELISA法检测血浆脂联素及sLOX-1浓度,同时检测相关生化指标。结果:1、2、3级组脂联素水平均低于健康对照组,且3级组脂联素水平明显低于1级组(P<0.01);相反,1、2、3级组sLOX-1的水平均高于对照组,且3级组LOX-1水平明显高于1级组(P<0.01);血浆脂联素和sLOX-1水平呈显著负相关(r=-0.903,P<0.05)。结论:原发性高血压的发病与血浆脂联素及sLOX-1水平有密切关系。 Objective To investigate the relations between adiponectin, LOX-1 and the development of essential hypertension. Methods 120 patients with essential hypertension were divided into 3 groups according to the levels of blood pressure : hypertension grade 1,2,3 groups with 37,40, and 43 cases, respectively ; another 40 normal controls as control group. Peripheral blood samples were collected from cubital vein, and the plasma concentrations of adiponectin and LOX-1 were measured by ELISA technique, and also the related biochemical indicators were tested. Results The plasma levets of adiponectin in hypertension grade 1,2,3 groups were significantly lower than that in control group, and that in hypertension grade 3 group was lower than that in hypertension grade 1 group (P 〈 0.01 ). The plasma levels of LOX-1 in hypertension grade 1,2,3 groups were significantly higher than that in control group, and that in hypertension grade 3 group was higher than that in hypertension grade 1 group (P 〈 0.01 ). Plasma level of LOX-I was negatively correlated with adiponectin (r = -0.903, P 〈 0.05). Conclusion Plasma levels of LOX-1 and adiponectin were closely related to essential hypertension.
出处 《实用医学杂志》 CAS 北大核心 2013年第12期1927-1929,共3页 The Journal of Practical Medicine
基金 广东省自然基金资助项目(编号:9151008901000039) 韶关市科技计划项目(编号:韶科[2012]38号)
关键词 原发性高血压 脂联素 LOX-1 Essential Hypertension Adiponectin LOX-1
  • 相关文献

参考文献13

  • 1李为民,刘巍.2005年中国高血压防治指南评介[J].中国实用内科杂志,2007,27(12):899-902. 被引量:73
  • 2Avery PJ, Patel S K, Ibrahim I M, et al. Common variation in the adiponect-in gene has an effect on systolic blood pressure[J].J Hum Hypertens, 2011 ,25(12) :719-724.
  • 3Liu M, Liu F. Transcriptional and post-translational regulation of adiponectin[J]. Biochem, 2009,425 (1) : 41-52.
  • 4XuJ, ZhuJ H, Shi MJ, et al. Value of serum soluble lectin-like oxidized low-density lipoprotein receptor-1 (LOX-I) and LOX-1 mRNA in peripheral mononuclear cells in early diagnosis of acute coronary syndrome[J]. Nan Fang Yi Ke Oa Xue Xue Bao, 201O,30(12):2749-275l.
  • 5Li B, Zhang L H, Yang X G, et al. Serum sLOX-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome[J]. Clin Invest Med, 2010,33 (6) : E398-404.
  • 6Kume N, Mitsuoka H, Hayashida K, et al. Soluble lectin-like oxidized LOL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome-comparison with other biomarkers[J].J Cardiol, 2010,56(2) :59-65.
  • 7莫新玲,王要鑫,谢福生,李全忠.脂联素及高敏C反应蛋白与原发性高血压合并痛风的关系[J].实用医学杂志,2011,27(10):1767-1769. 被引量:10
  • 8Mangge H, Almer G, Truschnig-Wilders M, et al. Inflammation, adiponectin , obesity and cardiovascular risk[J]. CUIT Med Chern, 2010,17(36) :4511-4520.
  • 9陈颖,陈大年.血凝素样氧化低密度脂蛋白受体-1与心血管疾病[J].实用医学杂志,2010,26(10):1688-1690. 被引量:2
  • 10Ohki I, Amida H , Yamada R, et al. Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LOL receptor (LOX-I)[J]. Biochim Biophys Acta, 2011,1814(2):345-354.

二级参考文献39

共引文献82

同被引文献62

  • 1Tang H, Sebastian B M, Axhemi A,et al. Ethanol-induced oxidative stress via the CYP2EI pathway disrupts adiponectin secretion from adipocytes[ J] .Alcohol Clin Exp Res,2012,36( 2 ) :214-222.
  • 2Addabbo F, Nacci C, De Benedietis L, et al. Gtobular adiponeetin counteracts VCAM-l-mediated monocyte adhesion via AdipoR1/ NF-κB/COX-2 signaling in human aortic endothelial cells[J]. Am J Physiol Endocrinol Metab, 2011,301 ( 6 ) : E1143-E1154.
  • 3Gouda Z, Mashaal G, Bello A, et al. Egypt information, prevention, and treatment of chronic kidney disease (EGIPT-CKD) programme: Prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt[J]. Saudi Journal of Kidney Diseases and Transplantation, 2011, 22(5): 1055.
  • 4Mongkolsomlit S, Patumanond J, Tawichasri C, et al. Meta-Regression of Risk Factors for Microalburninuria in Type 2 Diabetes[J]. Southeast Asian Journal of Tropical Medicine & Public Health, 2012, 43(2): 455-466.
  • 5Salvi E, Kutalik Z, Glorioso N, et al. Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase[J]. Hypertension, 2012, 59(2): 248-255.
  • 6Salvi E, Kutalik Z, Glorioso N, et al. Genomewide association study using a high-density single nucleotide polymorphism array and casecontrol design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase[J]. Hypertension, 2012, 59(2): 248-255.
  • 7Yokoyama H, Sone H, Saito K, et al. Flow-mediated dilation is associated with microalbuminuria independent of cardiovascular risk factors in type 2 diabetes-interrelations with arterial thickness and stiffness[J]. Journal of atherosclerosis and thrombosis, 2010,18(9): 74 4-752.
  • 8Ide L Y, Akani N A. Microalbuminuria: It's Significance, risk factors and methods ofdetection[J]. Nigerian Health Journal, 2013, 11(1): 1-7.
  • 9Van Der Tol A, Van Biesen W, De Groote G, et al. Microalbuminuria is more consistent in the presence of cardiovascular risk factors[J]. Journal of nephrology, 2013, 26(3): 580-585.
  • 10Jacob M, Hoepfner F, Ulrich C, et al. Microalburninuria and low-level microalbuminuria as markers of coronary heart disease progression[J]. European Heart Journal, 2013, 34(suppll): 4414.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部